Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NGX-4010 for painful HIV-associated neuropathy
2006-002185-19Phase 3Completed
- Sponsor
- NeurogesX
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of capsaicin in Neuralgia (3 arms), sponsored by NeurogesX. Primary endpoint: Primary efficacy endpoint. Started Jul 2006; status: completed.
02
Drugs
capsaicin
03
Conditions
Neuralgia
Beyond the preview
Go deeper on 2006-002185-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002185-19.